What is semaglutide?
Semaglutide is the active ingredient in Ozempic, Wegovy, and Rybelsus. Semaglutide is used for weight loss in specific patients, and also to lower blood sugar levels, and to reduce the risk of major cardiovascular events such as heart attack or stroke in certain patients. Semaglutide is a GLP-1 agonist that works by increasing insulin release, lowering the amount of glucagon released, delaying gastric emptying, and reducing appetite.

Semaglutide weight loss brand is Wegovy is the only semaglutide brand that is FDA brand approved for weight loss.

Semaglutide injections (Ozempic and Wegovy) are given as subcutaneous injections once a week. Rybelsus is a tablet that you take once a day in the morning, 30 minutes before eating, drinking, or taking any other medicines. You may eat, drink, or take oral medicine 30 minutes after taking Rybelsus.

Semaglutide is not for use in people with type 1 diabetes.

Semaglutide is not available as a generic medicine. Each of the different brands of semaglutide (Wegovy, Ozempic, Rybelus) are made by Novo Nordisk and are FDA-approved for different conditions.